Bitterman Robert J
Transaction: 06/26/2026
BUY
Change
+10,000
Price
$0.99
Filing
06/29/2026
Type
BUY
Phio Pharmaceuticals Corp.
PHIO • Biotechnology
$1.08
▼ -0.03 (-2.70%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$12.55M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 49.37Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.08
Change-2.70%
Shares Out11.62M
Market Cap$12.55M
Enterprise Value$-4.48M
52W Range0.81 - 4.19
Beta0.81
P/E-1.15
P/B0.76
P/FCF-1.17
EV/EBITDA0.39
EV/FCF0.42
Price$1.08
Change-2.70%
Shares Out11.62M
Market Cap$12.55M
Enterprise Value$-4.48M
52W Range0.81 - 4.19
Beta0.81
P/E-1.15
P/B0.76
P/FCF-1.17
EV/EBITDA0.39
EV/FCF0.42
Earnings Yield-87.13%
FCF Yield-85.42%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio49.37
Quick Ratio49.37
Volume99.89K
Avg Volume169.07K
EPS Surprise-0.10
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 49.37Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-09-05
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Bitterman Robert J
Transaction: 02/05/2026
BUY
Change
+120,000
Price
Not reported
Filing
02/06/2026
Type
BUY
BRADFORD PATRICIA A
Transaction: 02/05/2026
BUY
Change
+18,500
Price
Not reported
Filing
02/06/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Bitterman Robert J | BUY | +10,000 | $0.99 | 06/26/2026 | 06/29/2026 |
| Bitterman Robert J | BUY | +120,000 | Not reported | 02/05/2026 | 02/06/2026 |
| BRADFORD PATRICIA A | BUY | +18,500 | Not reported | 02/05/2026 | 02/06/2026 |
| Carson Lisa Cabott | BUY | +47,000 | Not reported | 02/05/2026 | 02/06/2026 |
| Deming David H | BUY | +23,800 | Not reported | 02/05/2026 | 02/06/2026 |
| Freeman Jonathan E | BUY | +16,600 | Not reported | 02/05/2026 | 02/06/2026 |
| Lockshin Curtis | BUY | +16,600 | Not reported | 02/05/2026 | 02/06/2026 |
| Bitterman Robert J | BUY | +5,000 | $1.03 | 12/31/2025 | 01/02/2026 |
| Bitterman Robert J | BUY | +5,000 | $1.02 | 12/23/2025 | 12/29/2025 |
| Bitterman Robert J | BUY | +5,000 | $1.14 | 11/21/2025 | 11/24/2025 |
| Bitterman Robert J | BUY | +5,000 | $1.27 | 11/18/2025 | 11/19/2025 |
| Bitterman Robert J | SELL | -4,111 | $2.32 | 09/11/2025 | 09/15/2025 |
| BRADFORD PATRICIA A | BUY | +18,800 | Not reported | 09/11/2025 | 09/15/2025 |
| Carson Lisa Cabott | BUY | +47,000 | Not reported | 09/11/2025 | 09/15/2025 |
| Freeman Jonathan E | BUY | +14,700 | Not reported | 09/11/2025 | 09/15/2025 |
| Lockshin Curtis | BUY | +16,200 | Not reported | 09/11/2025 | 09/15/2025 |
| Deming David H | BUY | +14,000 | Not reported | 09/11/2025 | 09/15/2025 |
| Ferrara Robert L | BUY | +23,000 | Not reported | 09/11/2025 | 09/15/2025 |
| Carson Lisa Cabott | OTHER | 0 | Not reported | 06/06/2025 | 06/18/2025 |
| Ferrara Robert L | BUY | +2,500 | $2.42 | 06/10/2025 | 06/11/2025 |